We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Seeks More EMA Guidance, Flexibility for Advanced Therapies
Industry Seeks More EMA Guidance, Flexibility for Advanced Therapies
To drive the manufacturing of advanced therapies, industry is asking the European Medicines Agency to provide further guidance, to harmonize EU regulations and to exercise flexibility.